NEW YORK (GenomeWeb News) – Under a new strategic partnership, TrimGen will develop technology for Spartan Bioscience and Spartan will distribute TrimGen products in Canada, Ottawa-based Spartan said today.
TrimGen has agreed to develop real-time PCR reagents and kits for the Spartan DX device. Coupling the Spartan DX with TrimGen’s real-time PCR assays allows Spartan to offer “a complete solution for rapid DNA testing,” Spartan Bioscience CEO Paul Lem said in a statement.
TrimGen is focused on developing nucleic acid-based molecular diagnostics for leukemia, cancer, and infectious diseases.
Spartan is aimed at developing applications “where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.”